Navigation Links
Apexus Announces HRSA's 340B Prime Vendor Contract Renewal
Date:9/11/2012

IRVING, Texas, Sept. 11, 2012 /PRNewswire/ -- The Health Resources and Services Administration (HRSA) has elected to continue its relationship with Apexus by renewing for another year the agreement making Apexus the government's prime vendor for the 340B program. HRSA chose to exercise this one year renewal following a careful audit and review of Apexus' proven ability to maintain, coordinate and advance the 340B Prime Vendor Program.

The agreement between Apexus and HRSA, effective September 10, 2009, has a term of two years, with three one-year renewal options. HRSA exercises the one-year renewal options each year after reviewing Apexus's abilities and performance against other potential vendors.

"We are pleased to continue our relationship with HRSA," said Christopher Hatwig, Vice President at Apexus. "As the government's prime vendor for the 340B program, we believe the program is an essential federal program, and we are committed to providing value to the eligible organizations we serve. Since our partnership began, in addition to regulatory discounts on covered outpatient drugs, the Program has added numerous value-added products and services."

The 340B Drug Pricing Program is a Federal program that requires drug manufacturers to provide outpatient drugs to eligible safety-net health organizations at a reduced price to ensure patient access to medications, which is a key component of successful clinical pharmacy services and providing a high-quality continuum of care. As the contractor to the 340B Prime Vendor, Apexus is responsible for negotiating pharmaceutical pricing below the 340B price as well as improving access to affordable medications by establishing a distribution network for pharmaceuticals to covered entities.

"We believe the 340B Drug Pricing Program helps improve access to affordable medications for covered entities and underserved patient groups," adds Hatwig. "Without the Program, we believe many of the nation's uninsured and under insured would not have adequate access to affordable medications. This Program helps alleviate additional financial burdens on the nation's safety net providers and American tax payers."

About Apexus
Founded in 2007, Apexus Inc., a nonprofit corporation, is the HRSA's Office of Pharmacy Affairs awarded contractor to serve as the prime vendor for the 340B Program. Based in Irving, Texas, the prime vendor's role is to secure sub-ceiling discounts on outpatient drug purchases and discounts on other pharmacy related products and services for participating public hospitals, community health centers, and other safety-net health care providers electing to join the program. For more information on Apexus, visit www.340Bpvp.com.


'/>"/>
SOURCE Apexus
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
2. Thoratec Announces Presentations At Upcoming Investor Conferences
3. Hemp, Inc. Division Marijuana Inc. Announces Medical Grow Tour Venue In Portland, Oregon
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
6. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
7. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
8. CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
11. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016  The Addiction Treatment Advisory Group ... Managed Care Pharmacy (AMCP), has released detailed findings ... the opioid addiction crisis, including through improved access ... ATAG,s newly released paper, "The Role of ... addresses many issues around gaps and barriers to ...
(Date:12/2/2016)... 2, 2016 Boston Scientific Corporation (NYSE: ... acquire certain manufacturing assets and capabilities of the Neovasc, ... biological tissue business, as well as a 15% equity ... in cash. The Neovasc advanced biological tissue business makes ... Scientific Lotus™ Valve System. * Upon completion of ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended ... Industrial Average edged 0.36% higher, to finish at 19,191.93; and ... broad based as six out of nine sectors ended the ... the following Services equities: Myriad Genetics Inc. (NASDAQ: ... Research Holdings Inc. (NASDAQ: INCR ), and La ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 is a ... versatile lower third titles with just a few clicks of the mouse," said Christina ... 30 lower third animations. Choose from various styles with accented animations, rigid boxes, simplistic ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... needy individuals and families from eight different sites throughout Miami-Dade and Broward counties. ... 1,000 volunteers worked very hard on Thanksgiving morning by putting together individual meals ...
(Date:12/2/2016)... ... December 02, 2016 , ... Date aired: ... of Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein , Sharon ... of Water, Global Climate Change and Your Health radio program syndicated on Voice ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... that we have been designated as a Cigna Infertility Center of Excellence. The ... performance standards. , “It’s an honor to be designated a Cigna Infertility ...
Breaking Medicine News(10 mins):